Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Active Iron is a consumer healthcare brand developed by Solvotrin Therapeutics, an Irish life sciences company specializing in advanced nutritional supplements. The company's core innovation is its patented "Active" platform technology, which uses denatured whey protein to encapsulate iron, protecting it from oxidation in the stomach. This targeted delivery system allows iron to be released in the small intestine, where it is naturally absorbed by the Divalent metal transporter 1 (DMT-1), thereby minimizing common gastrointestinal side effects such as nausea and constipation. Active Iron's product portfolio includes specialized formulations for women, pregnancy, and athletes, all of which are clinically proven to offer superior absorption compared to traditional ferrous sulfate. Headquartered in Cork, Ireland, the company maintains strong research ties with Trinity College Dublin and distributes its products globally through strategic partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Active Iron.